A 2026 update on the epidemiology of obesity, related cardio-kidney-liver metabolic complications and beyond; a call to action
Consulting or advice, Fees or honoraria, Oct 29, 2026
A real-world multicenter study of statins in compensated advanced chronic liver disease on hepatic decompensation and mortality outcomes
Grants or research support, Oct 14, 2026
Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: genetic evidence from large-scale phenomic analyses
Consulting or advice, Fees or honoraria, Jul 30, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts
Shares or equity, Jun 1, 2026
Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trials
Grants or research support, Mar 17, 2026
Metabolic dysfunction-associated steatotic liver disease is associated with vascular dysfunction in type 1 diabetes
Consulting or advice, Fees or honoraria, Grants or research support, Feb 25, 2026
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management
Consulting or advice, Fees or honoraria, Feb 13, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents
Consulting or advice, Fees or honoraria, Feb 9, 2026
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
Consulting or advice, Shares or equity, Feb 5, 2026
Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study
Consulting or advice, Fees or honoraria, Feb 4, 2026
Management of obesity in advanced chronic liver disease
Consulting or advice, Grants or research support, Jan 30, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillance
Consulting or advice, Jan 23, 2026
Effects of liraglutide treatment for 35-days on total and regional fat free, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study
Consulting or advice, Fees or honoraria, Jan 20, 2026
Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction- Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide
Shares or equity, Dec 1, 2025
Sarcopenia and MASLD: novel insights and the future
Consulting or advice, Fees or honoraria, Nov 5, 2025
Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis
Consulting or advice, Fees or honoraria, Oct 9, 2025
GDF15 is associated with hepatocellular senescence and correlates with mortality in patients with alcohol-associated hepatitis
Consulting or advice, Jun 10, 2025
Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis
Fees or honoraria, Grants or research support, May 5, 2025
The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality
Consulting or advice, Mar 25, 2025
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis
Consulting or advice, Grants or research support, Jan 17, 2025